title: Molecular mechanisms of drug resistance.
authors.affiliation: Department of Medicine, Medical University of Vienna, Austria. robert.mader@meduniwien.ac.at
authors.forename: R M
authors.initials: RM
authors.lastname: Mader
authors.forename: W M
authors.initials: WM
authors.lastname: Schmidt
authors.forename: G G
authors.initials: GG
authors.lastname: Steger
authors.forename: G
authors.initials: G
authors.lastname: Krupitza
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics / Q000473:pathology; D004260:DNA Repair; D004261:DNA Replication; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm; D044127:Epigenesis, Genetic; D005260:Female; D005472:Fluorouracil / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D015870:Gene Expression; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D008745:Methylation; D008938:Mitosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects; D051981:Uracil-DNA Glycosidase
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil; D018719:Erb-b2 Receptor Tyrosine Kinases; D051981:Uracil-DNA Glycosidase